Introduction
Cabergoline is a medication primarily used to treat conditions associated with excess prolactin, such as prolactinomas or hyperprolactinemia. It belongs to the class of drugs known as dopamine agonists, which mimic the action of dopamine in the brain.
The pharmacological action of Cabergoline 0.25 mg includes the inhibition of prolactin secretion. This medication is available at a competitive Cabergoline 0,25 mg price.
Mechanism of Action
Cabergoline primarily works by binding to dopamine D2 receptors in the pituitary gland. This leads to the following effects:
- Reduction in prolactin levels in the bloodstream.
- Suppression of the secretion of other hormones that may be affected by elevated prolactin.
- Potential shrinkage of prolactin-secreting tumors.
Indications
Cabergoline is indicated for the treatment of:
- Hyperprolactinemia
- Prolactin-secreting adenomas
- Menstrual disorders associated with hyperprolactinemia
Conclusion
In summary, Cabergoline 0.25 mg serves an essential role in managing conditions tied to excess prolactin. Its action as a dopamine agonist makes it effective in reducing prolactin secretion and addressing associated symptoms and disorders.